TAKEDA ITALIA S.P.A.
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- LANSOX capsule, hard 15 mg
- LANSOX capsule, hard 30 mg
- LANSOX orodispersible tablet 15 mg
- LANSOX orodispersible tablet 30 mg
- PANTECTA gastro-resistant tablet 20 mg
- PANTECTA gastro-resistant tablet 40 mg
- PANTOPAN gastro-resistant tablet 20 mg
- PANTOPAN gastro-resistant tablet 40 mg
- PANTOPAN tablet 40 mg
- PANTORC gastro-resistant tablet 20 mg
- PANTORC gastro-resistant tablet 40 mg
- PEPTAZOL gastro-resistant tablet 20 mg
- PEPTAZOL gastro-resistant tablet 40 mg
- RIOPAN chewable tablet 800 mg
- RIOPAN oral gel 80 mg/ml
- L02 - Terapia endocrina
- ENANTONE powder and solvent for suspension for injection 11.25 mg
- ENANTONE powder and solvent for suspension for injection 3.75 mg
- ENANTONE suspension for injection 1 mg/0.2 ml
- N02 - Analgésicos
- MATRIFEN transdermal patch 100 µg/h
- MATRIFEN transdermal patch 12 µg/h
- MATRIFEN transdermal patch 25 µg/h
- MATRIFEN transdermal patch 50 µg/h
- MATRIFEN transdermal patch 75 µg/h